Amunix Pharmaceuticals Competitors and Similar CompaniesClear all
Amunix Pharmaceuticals's competitors and similar companies include Remedy Plan, Rise Therapeutics, C4 Therapeutics and Genelux.
 Amunix Pharmaceuticals Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology. |  Remedy Plan Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis. |  Rise Therapeutics Rise Therapeutics is a biotech company that develops immunological-based biologics using an oral delivery platform. |  C4 Therapeutics C4 Therapeutics is a clinical-stage biotechnology company specializing in targeted protein degradation. |  Genelux Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform. | |
Founding Date | Founding Date 2006 | Founding Date 2011 | Founding Date 2014 | Founding Date 2015 | Founding Date 2001 |
Type | Type Subsidiary | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations HQ | Locations Rockville, US HQ | Locations Watertown, US HQ | Locations Thousand Oaks, US HQ |
Employees | Employees 42 | Employees 15 | Employees 196% increase | Employees 1045% decrease | Employees 157% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 416 m | Valuation ($) 106.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $35.9m (FY, 2025) | Revenue (est.) $8k (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($105m) (FY, 2025) | Net income ($32.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 190m | Total funding raised $ 10.1m | Total funding raised $ 200k | Total funding raised $ 223m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Remedy Plan
HQ
Employees
15
Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.
View companyRise Therapeutics
HQ
Rockville, US
Employees
19↑ 6% increase
Rise Therapeutics is a biotech company that develops immunological-based biologics using an oral delivery platform.
View companyC4 Therapeutics
HQ
Watertown, US
Employees
104↓ 5% decrease
C4 Therapeutics is a clinical-stage biotechnology company specializing in targeted protein degradation.
View companyGenelux
HQ
Thousand Oaks, US
Employees
15↑ 7% increase
Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform.
View company